We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Debiopharm Group™ Starts Phase I Clinical Trial with Debio 0932

News   Apr 28, 2010

 
Debiopharm Group™ Starts Phase I Clinical Trial with Debio 0932
 
 
 

RELATED ARTICLES

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

Perfecting a Method To Predict the Potential of New Drugs

News

Researchers are perfecting a method to predict the potential clinical implications of new drugs before clinical trials even start.

READ MORE

Blood Circulation Disorder Could Be an Autoimmune Disease

News

In a patient-based study, researchers have found evidence to suggest postural orthostatic tachycardia syndrome (POTS) could be an autoimmune disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE